Jamie L. Reynoso - 07 Jan 2024 Form 4 Insider Report for CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Role: CEO, Medicare Advantage
Signature: /s/Peter J. Rivas as attorney-in-fact for Jamie L. Reynoso
Issuer symbol: CLOV
Transactions as of: 07 Jan 2024
Net transactions value: -$15,551
Form type: 4
Filing time: 09 Jan 2024, 16:02:24 UTC
Previous filing: 05 Jan 2024
Next filing: 18 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLOV	Class A Common Stock	Tax liability	$15,551	-16,369	-0.65%	$0.9500	2,485,771	07 Jan 2024	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date.

Content

Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 7, 2024, due to the vesting of 25% of the original number of restricted stock units ("RSUs") granted to the Reporting Person on July 16, 2021, and timely reported on a Form 4 filed on July 20, 2021. The remaining RSUs will vest on January 7, 2025, subject to the continued service of the Reporting Person on such date.